1.Absence of lupus anticoagulants in Behcet's disease.
Dongsik BANG ; Hye Doo JI ; Yong Seop CHOI ; Sungnack LEE
Yonsei Medical Journal 1991;32(4):326-329
The presence of a lupus anticoagulant was evaluated in patients with Bechet's disease by the kaolin clotting time method. Four percents (three patients) of 69 patients analyzed were found positive for the lupus anticoagulant. However, no statistically significant association existed between the presence of this antibody and the presence of thrombosis, clinical activity, clinical type, antinuclear antibodies and the positive VDRL test.
Behcet Syndrome/*immunology
;
Cardiolipins/immunology
;
Female
;
Human
;
Lupus Coagulation Inhibitor/*analysis
;
Male
2.A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma.
Chan Jeoung PARK ; Han Ik CHO ; Sang In KIM
Journal of Korean Medical Science 1991;6(1):1-6
The authors conducted an investigation focusing mainly on the activities of the inhibitory factors of the coagulation and fibrinolysis processes in 35 normal adults and 72 liver cirrhosis and/or hepatoma patients. The activities of antithrombin III, protein C, and alpha 2-plasmin inhibitor were reduced to less than 50% in patients with decreased hepatic synthetic function while lupus anticoagulant was detected in more than 50% of patients with decreased hepatic synthetic function. Hemostatic abnormalities in advanced lived diseases may be caused partly by a decrease of coagulation and fibrinolysis inhibitors and the presence of lupus anticoagulant.
Adult
;
Antifibrinolytic Agents/blood
;
Blood Coagulation Factors/antagonists & inhibitors/immunology/metabolism
;
Carcinoma, Hepatocellular/*blood
;
Hemostasis
;
Humans
;
Liver Cirrhosis/*blood
;
Liver Neoplasms/*blood
;
Lupus Coagulation Inhibitor
3.Lupus anticoagulant-hypoprothrombinemia in healthy adult.
Choon Hae CHUNG ; Chi Young PARK
The Korean Journal of Internal Medicine 2008;23(3):149-151
The presence of lupus anticoagulant is associated with an elevated risk of venous and arterial thrombosis, and recurrent miscarriages as well. For some cases, this disease can present with bleeding as a consequence of lupus anticoagulant hypoprothrombinemia (LAHPS). LAHPS is a rare disease and it is reported to be most frequent in young females with/without systemic lupus erythematosus or in healthy children who are suffering with a viral infection. In such cases, steroid therapy is usually effective in normalizing the biological abnormalities and controlling the bleeding problems. A 34-year-old previously healthy man was admitted to our department because of his prolonged coagulation times; these abnormalities were discovered before performing orthopedic surgery. The prothrombin time (PT) was 15.2 sec, and the activated partial thromboplastin time (APTT) was 37.7 sec. A 1:1 dilution of patient plasma with normal plasma nearly corrected the PT, but this failed to correct the APTT. Evaluation of the clotting factors revealed decreased levels of factors II, V, VIII, IX and XI. The presence of LA was demonstrated by the dRVVT test, and the patient was diagnosed with LAHPS. He was successfully treated with corticosteroid before performing the orthopedic surgery.
Adrenal Cortex Hormones/therapeutic use
;
Adult
;
Humans
;
Hypoprothrombinemias/*diagnosis/drug therapy/immunology/physiopathology
;
Lupus Coagulation Inhibitor/*immunology
;
Lupus Erythematosus, Systemic/*diagnosis/immunology/physiopathology
;
Male
;
Partial Thromboplastin Time
;
Preoperative Care
;
Prothrombin Time
4.Prevalence and Clinical Associations of Lupus Anticoagulant, Anticardiolipin Antibodies, and Anti-beta2-glycoprotein I Antibodies in Patients with Systemic Lupus Erythematosus.
Kwang Sook WOO ; Kyung Eun KIM ; Jeong Man KIM ; Jin Yeong HAN ; Won Tae CHUNG ; Kyeong Hee KIM
The Korean Journal of Laboratory Medicine 2010;30(1):38-44
BACKGROUND: The presence of antiphospholipid antibodies (aPLs) is associated with the clinical features of antiphospholipid syndrome (APS), which comprises venous and arterial thrombosis and pregnancy loss, and systemic lupus erythematosus (SLE). The prevalence of aPLs has been reported to be different in patient populations affected by either of these conditions. We performed a retrospective study to evaluate the prevalence and clinical associations of aPLs, including lupus anticoagulant (LAC), anticardiolipin (aCL), and anti-beta2-glycoprotein I antibodies (anti-beta2-GPI) in a cohort of Korean patients with SLE. METHODS: This study included samples from 88 SLE patients for whom aPL testing had been advised between June 2006 and July 2009 at the Dong-A University Hospital. Serum and plasma samples were tested for LAC, aCL (IgG, IgM), and anti-beta2-GPI (IgG, IgM) antibodies. Clinical data from patients were obtained from a review of medical records. RESULTS: LAC was the most common (34.1% of total patients, 30/88) antibody, followed by IgM aCL (31.8%, 28/88), IgG aCL (18.2%, 16/88), and IgM and IgG anti-beta2-GPI (both 5.7%, 5/88 each). Positivity for LAC was strongly associated with venous/arterial thrombosis (P=0.002). CONCLUSIONS: LAC was the most common antibody detected in Korean SLE patients and is shown to have a significant association with the presence of venous/arterial thrombosis. The measurement of LAC may be clinically useful in identifying patients with SLE who are at a high risk for venous/arterial thrombosis.
Adolescent
;
Adult
;
Antibodies, Anticardiolipin/*blood
;
Antibodies, Antiphospholipid/*blood
;
Cohort Studies
;
Female
;
Humans
;
Immunoglobulin G/blood
;
Immunoglobulin M/blood
;
Lupus Coagulation Inhibitor/*blood
;
Lupus Erythematosus, Systemic/epidemiology/*immunology
;
Male
;
Middle Aged
;
Pregnancy
;
Prevalence
;
Retrospective Studies
;
Risk Factors
;
Venous Thrombosis/epidemiology/immunology
5.Usefulness of Silica Clotting Time for Detection of Lupus Anticoagulants.
Hye Ryun LEE ; Ji Eun KIM ; Soo Hyun HA ; Hyun Kyung KIM ; Seonyang PARK ; Han Ik CHO
The Korean Journal of Laboratory Medicine 2009;29(6):497-504
BACKGROUND: The presence of lupus anticoagulants (LA) is a strong risk factor for thrombosis in antiphospholipid syndrome. We investigated the usefulness of addition of silica clotting time (SCT) to the pre-existing dilute Russell's viper venom test (dRVVT) for detection of LA. Also, we analyzed differences in the thrombotic features and the characteristics of antiphospholipid antibodies between dRVVT and SCT. METHODS: A total of 167 patients positive for LA or anti-cardiolipin (anti-CL) antibody and 76 healthy controls were enrolled. The dRVVT and SCT were used for detection of LA. Anti-CL, anti-beta2-glycoprotein I (anti-beta2 GPI) and anti-prothrombin (anti-PT) antibodies were measured using commercial ELISA kits. RESULTS: In detection of thrombosis, the sensitivity of the combined test of SCT and dRVVT was 56.4%, which was higher than that of dRVVT alone (46.2%) or SCT alone (23.1%). The specificity of the combined test (80.9%) was comparable to that of dRVVT (81.9%). Also, odds ratio for predicting thrombosis was higher in the combined test than in dRVVT or SCT alone. When normalized LA ratio of the two tests was compared, the group of patients with higher ratio of SCT showed significantly higher prevalence of recurrent abortion and higher positivity of IgG types of anti-CL, anti-beta2 GPI and anti-PT than the group with higher ratio of dRVVT. CONCLUSIONS: Addition of SCT to dRVVT can improve the detection sensitivity of thrombosis in LA test. And the high normalized LA ratio of SCT may be a useful parameter for detection of recurrent abortion.
Adult
;
Aged
;
Antibodies, Anticardiolipin/analysis
;
Antibodies, Antiphospholipid/analysis
;
Blood Coagulation Tests/*methods
;
Female
;
Humans
;
Immunoglobulin G/analysis
;
Immunoglobulin M/analysis
;
Lupus Coagulation Inhibitor/*blood
;
Male
;
Middle Aged
;
Prothrombin/immunology
;
Prothrombin Time/methods
;
Reagent Kits, Diagnostic
;
Sensitivity and Specificity
;
Silicon Dioxide/*chemistry
;
Thrombosis/diagnosis
;
beta 2-Glycoprotein I/immunology